| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 08/02/2000 | EP0948606B1 Peniophora phytase |
| 08/02/2000 | EP0672162B1 Enhanced production of taxol and taxanes by cell cultures of taxus species |
| 08/02/2000 | EP0554383B1 Blood coagulation protein antagonists and uses therefor |
| 08/02/2000 | CN1261918A Protein producing cell containing multiple copies of a desired gene and a screenable marker but no selection marker |
| 08/02/2000 | CN1261914A Alkaline xyloglucanase |
| 08/02/2000 | CN1261627A L-glutaminic acid producing bacteria and method for producing L-glutaminic acid |
| 08/02/2000 | CN1261626A Method for producing L-amino acid |
| 08/01/2000 | US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| 08/01/2000 | US6096869 Treatment of papillomavirus-associated lesions |
| 08/01/2000 | US6096866 Netrins |
| 08/01/2000 | US6096862 Multimeric antiviral agent |
| 08/01/2000 | US6096708 Insecticides |
| 08/01/2000 | US6096549 Method of selection of allelic exchange mutants |
| 08/01/2000 | US6096547 Growing dicotyledon cells containing an expression cassette including regulatory sequences and the structural gene coding for polypeptide of interest; produces physiologically active proteins |
| 08/01/2000 | US6096538 Retroviral vectors |
| 08/01/2000 | US6096529 Recombinant α-2,3-sialyltransferases and their uses |
| 08/01/2000 | US6096527 Nucleic acids encoding protein tryosine kinases |
| 08/01/2000 | US6096516 cDNAs encoding murine antibody against human plasma apolipoprotein B-100 |
| 08/01/2000 | US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096512 Cloned DNA encoding a UDP-GalNAc: Polypeptide, N-acetylgalactosaminyltransferase |
| 08/01/2000 | US6096507 Methods for identifying a compound that binds to a human 5-HT1E receptor |
| 08/01/2000 | US6096506 Antibodies specific for growth differentiation factor-8 and methods of using same |
| 08/01/2000 | US6096323 Vaccine against papillomatous digital dermatitis (PDD) |
| 08/01/2000 | US6096322 Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing |
| 08/01/2000 | US6096319 Peptides with amino acid sequences |
| 08/01/2000 | US6096306 Strains of Bacillus thuringiensis and pesticide composition containing them |
| 08/01/2000 | US6096305 Receptor that binds IL-17 |
| 08/01/2000 | CA2297440A1 Levodione reductase |
| 08/01/2000 | CA2185436C Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases |
| 08/01/2000 | CA2175061C Muteins of beta-galactosidase fragments having increased activity |
| 08/01/2000 | CA2175060C Oxidation-resistant muteins of beta-galactosidase fragments |
| 08/01/2000 | CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/01/2000 | CA2099976C Repressors of the trans-activating function of papillomavirus e2 proteins |
| 08/01/2000 | CA2047717C Monoclonal antibodies for small moieties, methods therefor |
| 08/01/2000 | CA1341065C Detection of a unique chlamydia strain associated with acute respiratory disease |
| 07/29/2000 | CA2258972A1 Apoptosis inhibitory protein, gene encoding the protein and cdna thereof |
| 07/28/2000 | CA2411293A1 Novel azalides and methods of making same |
| 07/27/2000 | WO2000043549A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | WO2000043523A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043515A2 Methods of monitoring hiv drug resistance |
| 07/27/2000 | WO2000043503A1 Improved phytases |
| 07/27/2000 | WO2000043496A1 MULTI-ENZYME PRODUCT WITH GLUCOAMYLASE, PROTEOLYTIC AND XYLANASE ACTIVITIES AND METHOD FOR PRODUCING SAME BY SOLID STATE FERMENTATION OR WHEAT BRAN WITH $i(ASPERGILLUS NIGER) |
| 07/27/2000 | WO2000027998A3 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 07/27/2000 | WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 07/27/2000 | WO2000023429A3 Stereoselective process for producing cryptophycins |
| 07/27/2000 | WO2000012684A3 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 07/27/2000 | DE19960271A1 Sarcosine oxidase, useful for diagnosing diseases such as nephropathy, hydrolyzes 1 mol sarcosine oxidatively |
| 07/27/2000 | CA2360803A1 Lipophilic quenching of viral inactivating agents |
| 07/27/2000 | CA2360667A1 Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2356642A1 Improved phytases |
| 07/26/2000 | EP1022341A1 Method for producing xylitol or d-xylulose |
| 07/26/2000 | EP1022339A1 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 07/26/2000 | EP1022338A2 Viral vaccines |
| 07/26/2000 | EP1022333A1 Human tumor suppressor gene |
| 07/26/2000 | EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
| 07/26/2000 | EP1022329A1 Multi-enzyme product comprising glucoamylolytic, proteolytic and xylanolytic activities, and process to produce it by solid state fermentation of wheat bran by Aspergillus niger |
| 07/26/2000 | EP1021556A1 Assay using marked microbial host cell strains |
| 07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
| 07/26/2000 | EP1021527A1 Plant and viral promoters |
| 07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
| 07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
| 07/26/2000 | EP0786084A4 Method for screening compositions |
| 07/26/2000 | EP0769054B1 Immunomodulators |
| 07/26/2000 | EP0629293B1 Assay for adrenal autoantibodies |
| 07/26/2000 | CN1261402A Plant and viral promotors |
| 07/26/2000 | CN1261101A Method for dwarfing plants |
| 07/26/2000 | CA2296965A1 Use of bacterium for manufacture of a vaccine |
| 07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
| 07/25/2000 | US6093796 Recombinant hK2 polypeptide |
| 07/25/2000 | US6093695 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |
| 07/25/2000 | US6093563 Chondroitin lyase enzymes |
| 07/25/2000 | US6093553 Immortalized brain endothelial cells |
| 07/25/2000 | US6093545 Contacting the sample with nucleic acid probe or primer and detecting hybridization to the target nucleic acid; diagnosis of nervous system disorders including eating and sleep disorders, irritable bowel and glandular disorders |
| 07/25/2000 | US6093540 Method for diagnosing a disorder characterized by expression of a BAGE tumor rejection antigen precursor |
| 07/25/2000 | US6093394 Vaginal lactobacillus medicant |
| 07/25/2000 | CA2295354A1 Culture medium for culturing lactobacillus clearans, and method for preserving said strain |
| 07/25/2000 | CA2286314A1 Human tumor suppressor gene |
| 07/25/2000 | CA2160131C New bacillus thuringiensis strains and their insecticidal proteins |
| 07/25/2000 | CA2109727C Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 07/25/2000 | CA2015077C A yeast cell of the genus schwanniomyces |
| 07/25/2000 | CA2010256C Protein anti-cancer agent |
| 07/20/2000 | WO2000042429A2 In vitro model for gastrointestinal inflammation |
| 07/20/2000 | WO2000042204A2 Trans-acting factors in yeast |
| 07/20/2000 | WO2000042203A2 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
| 07/20/2000 | WO2000042195A2 Schizochytrium pks genes |
| 07/20/2000 | WO2000042188A2 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | WO2000042175A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | WO2000042171A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling |
| 07/20/2000 | WO2000042170A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/20/2000 | WO2000042168A2 Bifidobacterium in the treatment of inflammatory disease |
| 07/20/2000 | WO2000042066A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 07/20/2000 | WO2000042042A2 High affinity inhibitors for target validation and uses thereof |
| 07/20/2000 | WO2000041707A2 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 07/20/2000 | WO2000041576A1 Improved microbial preparations |